Setterwalls advises Integrum in connection with the public offer from OsteoCentrics

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a wholly owned subsidiary of OsteoCentric Technologies, Inc., has announced a recommended public offer to the shareholders of Integrum AB to transfer all of the shares in Integrum AB to OsteoCentric.

The total value of the offer is approximately SEK 939 million. Setterwalls advises Integrum in connection with the public offer.

Integrum AB is a medical technology company which develop and market a system for bone-anchored prostheses. Integrum’s class B shares are listed on Nasdaq First North Growth Market.